Evolus, Inc. (EOLS) Stock Ticker
EOLS right now
Market factors today
Unlock the full EOLS picture
About Evolus, Inc.
Evolus, Inc. is a performance beauty enterprise that furnishes the United States market with medical aesthetic solutions for healthcare professionals and their patients. A key product in its portfolio is Jeuveau, a proprietary 900 kilodalton purified botulinum toxin type A formulation. This product is specifically designed for adults seeking the temporary smoothing of moderate to severe glabellar (frown) lines. Founded in 2012, Evolus, Inc. maintains its corporate headquarters in Newport Beach, California.
EOLS stock facts
| Ticker symbol | EOLS |
| Exchange | NASDAQ Global Market |
| Sector | Healthcare |
| Industry | Drug Manufacturers - Specialty & Generic |
| Market cap | $524.9M |
| CEO | David Moatazedi |
| Employees | 353 |
| Headquarters | Newport Beach, CA, US |
| IPO date | 2018-02-08 |
| Website | www.evolus.com |
What you can see for EOLS on Tickr
Live EOLS price chart with overlays, the options chain, implied move, IV rank, options flow and Strategy Lab, financial statements and consensus estimates, analyst ratings, catalysts, news with AI scoring, and an AI chat that has read the EOLS report.
Rankings
FAQ
What is the ticker symbol for Evolus, Inc.?
The ticker symbol for Evolus, Inc. is EOLS, listed on the NASDAQ Global Market.
What is EOLS?
Evolus, Inc. is a performance beauty enterprise that furnishes the United States market with medical aesthetic solutions for healthcare professionals and their patients. A key product in its portfolio is Jeuveau, a proprietary 900 kilodalton purified botulinum toxin type A formulation. This product is specifically designed for adults seeking the temporary smoothing of moderate to severe…